SF-018-1 Enzyme/prodrug cancer therapy mediated by armed oncolytic HSV vectors
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-03-05
著者
-
Tanabe Kenneth
Div Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical school
-
Yamada Suguru
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Fuchs Bryan
Div Surgical Oncology, Harvard Medical School and Massachusetts General Hospital
-
Kuroda Toshihiko
Div Surgical Oncology, Harvard Medical School and Massachusetts General Hospital
-
Tanabe Kenneth
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Fuchs Bryan
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Kuroda Toshihiko
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
関連論文
- SF-018-1 Enzyme/prodrug cancer therapy mediated by armed oncolytic HSV vectors
- IS-1-4 Surgical management of colorectal carcinoma liver metastases(Strategy for treating liver metastasis from colorectal cancer,International Symposium(1))
- SF-018-5 Erlotinib chemoprevention of hepatocellular carcinoma in a rat model of cirrhosis